FDA Inspection 1267869 — Radnostix

Radnostix — FEI 3003350319

The FDA completed an inspection of Radnostix on Apr 25, 2025 in Idaho Falls, ID. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Apr 25, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Idaho Falls, ID (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
189021 CFR 211.165(e)Test methods
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.